Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicoletta Pedemonte

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Current Pharmaceutical Design|October 11, 2016
RNF5, DAB2 and Friends: Novel Drug Targets for Cystic FibrosisElvira Sondo, Emanuela Pesce, Valeria Tomati, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2020
Synthesis and biological evaluation of thiazole derivatives on basic defects underlying cystic fibrosisEmanuela Pesce, Nicoletta Pedemonte, Alberto Leoni, et al.
American Journal of Physiology. Cell Physiology|January 8, 2010
Influence of cell background on pharmacological rescue of mutant CFTRNicoletta Pedemonte, Valeria Tomati, Elvira Sondo, et al.
Expert Opinion on Pharmacotherapy|June 28, 2023
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?Kathryn E Oliver, Marianne S Carlon, Nicoletta Pedemonte, et al.
Frontiers in Immunology|May 23, 2019
High-Content Screening Identifies Vanilloids as a Novel Class of Inhibitors of NET FormationElvira Sondo, Roberta Bertelli, Emanuela Pesce, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2024
Targeting ubiquitination machinery in cystic fibrosis: Where do we stand?Tsukasa Okiyoneda, Christian Borgo, Valentina Bosello Travain, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 17, 2017
Therapeutic approaches to CFTR dysfunction: From discovery to drug developmentHongyu Li, Emanuela Pesce, David N Sheppard, et al.
European Journal of Medicinal Chemistry|August 15, 2012
Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activatorsSonja Visentin, Giuseppe Ermondi, Claudio Medana, et al.
Journal of Medicinal Chemistry|April 4, 2022
Proteostasis Regulators in Cystic Fibrosis: Current Development and Future PerspectivesIrene Brusa, Elvira Sondo, Federico Falchi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2019
CFTR processing, trafficking and interactionsMargarida D Amaral, Darren M Hutt, Valeria Tomati, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Current Pharmaceutical Design|October 11, 2016
RNF5, DAB2 and Friends: Novel Drug Targets for Cystic FibrosisElvira Sondo, Emanuela Pesce, Valeria Tomati, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2020
Synthesis and biological evaluation of thiazole derivatives on basic defects underlying cystic fibrosisEmanuela Pesce, Nicoletta Pedemonte, Alberto Leoni, et al.
American Journal of Physiology. Cell Physiology|January 8, 2010
Influence of cell background on pharmacological rescue of mutant CFTRNicoletta Pedemonte, Valeria Tomati, Elvira Sondo, et al.
Expert Opinion on Pharmacotherapy|June 28, 2023
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?Kathryn E Oliver, Marianne S Carlon, Nicoletta Pedemonte, et al.
Frontiers in Immunology|May 23, 2019
High-Content Screening Identifies Vanilloids as a Novel Class of Inhibitors of NET FormationElvira Sondo, Roberta Bertelli, Emanuela Pesce, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2024
Targeting ubiquitination machinery in cystic fibrosis: Where do we stand?Tsukasa Okiyoneda, Christian Borgo, Valentina Bosello Travain, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 17, 2017
Therapeutic approaches to CFTR dysfunction: From discovery to drug developmentHongyu Li, Emanuela Pesce, David N Sheppard, et al.
European Journal of Medicinal Chemistry|August 15, 2012
Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activatorsSonja Visentin, Giuseppe Ermondi, Claudio Medana, et al.
Journal of Medicinal Chemistry|April 4, 2022
Proteostasis Regulators in Cystic Fibrosis: Current Development and Future PerspectivesIrene Brusa, Elvira Sondo, Federico Falchi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2019
CFTR processing, trafficking and interactionsMargarida D Amaral, Darren M Hutt, Valeria Tomati, et al.
Pageof 13